Liquid AbobotulinumtoxinA: Pooled Data From Two Double-Blind, Randomized, Placebo-Controlled Phase III Studies of Glabellar Line Treatment
Sign Up to like & getrecommendations! Published in 2022 at "Dermatologic Surgery"
DOI: 10.1097/dss.0000000000003594
Abstract: Supplemental Digital Content is Available in the Text. BACKGROUND AbobotulinumtoxinA (aboBoNT-A) solution is a new ready-to-use formulation developed to reduce preparation time and improve reproducibility of injections. OBJECTIVE To further evaluate treatment of moderate-to-severe glabellar… read more here.
Keywords: placebo; pooled data; treatment; iii studies ... See more keywords